TCM
EGRX
Tang Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-118,857
| Closed | -$443K | – | 194 |
|
|
2024
Q3 | $443K | Hold |
118,857
| – | – | 0.03% | 136 |
|
|
2024
Q2 | $666K | Hold |
118,857
| – | – | 0.07% | 101 |
|
|
2024
Q1 | $623K | Hold |
118,857
| – | – | 0.06% | 92 |
|
|
2023
Q4 | $622K | Hold |
118,857
| – | – | 0.06% | 111 |
|
|
2023
Q3 | $1.87M | Hold |
118,857
| – | – | 0.26% | 73 |
|
|
2023
Q2 | $2.31M | Buy |
118,857
+38,857
| +49% | +$755K | 0.34% | 67 |
|
|
2023
Q1 | $2.27M | Sell |
80,000
-38,857
| -33% | -$1.1M | 0.34% | 63 |
|
|
2022
Q4 | $3.47M | Hold |
118,857
| – | – | 0.5% | 48 |
|
|
2022
Q3 | $3.14M | Buy |
+118,857
| New | +$3.14M | 0.39% | 59 |
|
|
2020
Q4 | – | Sell |
-62,262
| Closed | -$2.65M | – | 22 |
|
|
2020
Q3 | $2.65M | Sell |
62,262
-193,354
| -76% | -$8.21M | 0.48% | 16 |
|
|
2020
Q2 | $12.3M | Hold |
255,616
| – | – | 1.19% | 13 |
|
|
2020
Q1 | $11.8M | Buy |
+255,616
| New | +$11.8M | 1.65% | 12 |
|